Effects of Prisma® Skin dermal regeneration device containing glycosaminoglycans on human keratinocytes and fibroblasts

Prisma® Skin is a new pharmaceutical device developed by Mediolanum Farmaceutici S.p.a. It includes alginates, hyaluronic acid and mainly mesoglycan. The latter is a natural glycosaminoglycan preparation containing chondroitin sulfate, dermatan sulfate, heparan sulfate and heparin and it is used in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cell Adh Migr
Päätekijät: Belvedere, Raffaella, Bizzarro, Valentina, Parente, Luca, Petrella, Francesco, Petrella, Antonello
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5927688/
https://ncbi.nlm.nih.gov/pubmed/28795878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19336918.2017.1340137
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia